EUVIMEDEUVIMED entdecken
Crossref

Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence

Vinotha Thomas, John Dickson Calvin Devadasan, Neenu Oliver John, Jeba Karunya Reddy, Arvind Sathyamurthy, Dhanya Susan Thomas, Gnanadurai John Fletcher, Rajesh Kannangai, Anuradha Chandramohan, Betty Simon, Anitha Thomas, Thomas Samuel Ram und 2 weitere

Cancer Causes & Control · 2026-07 · 37 (7)

DOI: 10.1007/s10552-026-02201-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, online erschienen am 25.06.2026. Verfasst von Vinotha Thomas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, 632004, India. thomasvinotha@gmail.com. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Papillomavirus Infections, Human Papillomavirus Viruses. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Christian Medical College, Vellore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The detection of human papilloma virus (HPV) in serum after treatment for cervical cancer warrants further investigation.

Objectives

To study the prevalence of serum HPV and correlate its presence with cervical cancer recurrence.

Methods

This prospective cross-sectional study recruited 100 patients following treatment of HPV-associated cervical cancer between January 2023 and March 2024 at a tertiary care centre in South India. Patients who had completed treatment within the past 3 years were included. After obtaining consent, a one-time serum sample for HPV detection was analysed using a multiplex real-time PCR AnyplexTM II HPV HR detection assay (Seegene, Seoul, South Korea). The prevalence of serum HPV was correlated with disease recurrence and evaluated by Fisher’s Exact test. The log-rank test assessed the differences in disease-free survival between cases with and without measurable serum HPV.

Results

Among the 100 patients, the prevalence of serum HPV was 18% (18/100), with genotype 16 being found in 83.3% (15/18) of cases. There were 27 recurrences, of which 15 (55.6%) had detectable serum HPV DNA. Disease recurrence was significantly associated with serum HPV (odds ratio: 29.17, 95% confidence interval: 7.32–116.24). Higher serum HPV DNA levels, as determined by semi-quantification (2 + and 3 +), were associated with an increased hazard ratio for recurrence (58.33, CI: 6.83–498.23). Kaplan–Meier disease-free estimates revealed a significant association between recurrence and serum HPV prevalence ( p = 0.000).

Conclusion

Serum HPV can be used in the detection of recurrence in post-treatment surveillance of cervical cancer and should be validated in a prospective, longitudinal study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsNeoplasm Recurrence, LocalPapillomavirus InfectionsHuman Papillomavirus VirusesHumansFemaleProspective StudiesPrevalenceCross-Sectional StudiesMiddle AgedAdultDNA, ViralIndiaPapillomaviridae

Stichwörter der Autor:innen

Cervical cancerCervical cancer recurrenceHuman papilloma virus in serum

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, 632004, India. thomasvinotha@gmail.com.
  • Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India.
  • Radiation Oncology, Unit1, Christian Medical College, Vellore, Tamil Nadu, India.
  • Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
  • Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India.
  • Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India.

Förderung

  • Christian Medical College, Vellore

Zitieren

APA

Thomas, V., Devadasan, J. D. C., John, N. O., Reddy, J. K., Sathyamurthy, A., Thomas, D. S., Fletcher, G. J., Kannangai, R., Chandramohan, A., Simon, B., Thomas, A., Ram, T. S., Rebekah, G., & Abraham, P. (2026). Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence. Cancer Causes & Control, 37(7). https://doi.org/10.1007/s10552-026-02201-9

Vancouver

Thomas V, Devadasan JDC, John NO, Reddy JK, Sathyamurthy A, Thomas DS, et al. Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence. Cancer Causes & Control. 2026;37(7). doi:10.1007/s10552-026-02201-9

BibTeX
@article{Thomas2026,
  author = {Thomas, Vinotha and Devadasan, John Dickson Calvin and John, Neenu Oliver and Reddy, Jeba Karunya and Sathyamurthy, Arvind and Thomas, Dhanya Susan and Fletcher, Gnanadurai John and Kannangai, Rajesh and Chandramohan, Anuradha and Simon, Betty and Thomas, Anitha and Ram, Thomas Samuel and Rebekah, Grace and Abraham, Priya},
  title = {Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence},
  journal = {Cancer Causes & Control},
  year = {2026},
  volume = {37},
  number = {7},
  doi = {10.1007/s10552-026-02201-9}
}
Kostenlos starten →